PRA off to a ‘strong start’ in 2015

PRA off to a ‘strong start’ in 2015

By Zachary Brennan

CRO PRA Health Sciences saw its Q1 revenue climb about 10% on a constant currency basis compared to the same quarter last year.

Aurobindo sets eyes on pharmaceutical API CRAMS biz

Aurobindo sets eyes on API CRAMS biz

By Natalie Morrison

Aurobindo has announced long term plans to steer away from its generics making business in a bid to focus on long term API manufacturing partnerships.